PrimeCell Group boasts of an extensive portfolio of products ranging from Advanced therapy medical products (ATMP), cell and tissue transplants products through to novel material products.
Companies of PrimeCell Therapeutics develop cell therapy and tissue engineering products based on nano-materials. One of the key products of PrimeCell Group, currently on the market, is an autologous chondrocyte implant, namely, NTC chondrograft®.
Additional products, which are currently in the development process, are research and development (R&D) products, pre-clinical stage products, and products in clinical trials.
Apart from the unique medical products which are used for the treatment of patients, PrimeCell Group develops modern high-tech technologies which are designed for the production of its products.